logo
The fiery secret to a longer life might be hiding in your spice rack

The fiery secret to a longer life might be hiding in your spice rack

Fox News3 days ago

Is spicy food healthy for you?
Spicy foods can help with weight control, plus reduce the risk of cancer and heart disease, studies have shown — and consuming more spices may also contribute to a longer lifespan.
Bryan Quoc Le, Ph.D., a food scientist with Mendocino Food Consulting, spoke to Fox News Digital about the benefits of spice and how to incorporate more heat into your diet.
The California-based expert cited studies that uncovered the ability of capsaicin — found in chili peppers — to alter mice's microbiomes by boosting beneficial bacteria while diminishing harmful bacteria.
"This, in turn, results in a greater release of an amino acid called tryptophan, which these beneficial bacteria produce," he said.
"Tryptophan is an important precursor to neurotransmitters, such as serotonin, which [are] involved in mood, sleep and digestion."
Capsaicin, the compound that causes heat in peppers, can also provide "serious benefits" when consumed at a low daily dose of 0.01%, the food scientist said.
"A good quality hot sauce should add both flavor and heat and blend well with the flavors of the dish."
"That's just enough heat to taste, but not so much to overwhelm your stomach," Le noted.
What dishes taste best with spice? Le suggested meat-forward savory dishes, including stews, chilis, roast chicken and tacos.
"A good quality hot sauce should add both flavor and heat and blend well with the flavors of the dish," he advised.
For those who are completely unaccustomed to spice, Le suggested pickled pepperoncinis as an easy introduction to hotter foods.
"They're mild, a bit acidic and pack bold flavor without leaving you with a heavy residue of spice that you need to rinse out with milk," Le said.
"From there, you can venture into poblano, serrano or jalapeño peppers. These are great seared to tone down the heat, but still lend delicious flavor to a dish."
The peppers that pack a serious punch include scotch bonnets, habaneros, ghost peppers and Carolina reapers, which are "not for the faint of heart," Le said.
"Carolina reapers in particular have been bred with heat in mind and are some of the hottest peppers in the world," he warned.
Fox News Digital also spoke with Ken Grey, an advanced practitioner (AP) and doctor of Oriental medicine (DOM).
Grey of Jupiter, Florida, follows Eastern medicine practices and believes that spicy food has a direct impact on the small intestine and heart.
"Foods that are naturally hot or spicy can help increase circulation and metabolism, thereby assisting with removing qi [energy] and blood flow blockages, improving heart health and digestion, while aiding in weight loss," Grey said.
"Some helpful foods in this category are chili peppers, cinnamon, nutmeg, cloves, cardamom, garlic and ginger."
Grey also advised home cooks to pay attention to the Scoville scale, which measures how hot peppers are.
Bell peppers typically clock 0 Scoville heat units (SHU) while jalapeños can be as high as 8000 SHUs, Grey said.
Grey did note that "balance is key."
"Hotter spices and peppers should be taken in moderation so as not to swing the pendulum too far in one direction."
"Hotter spices and peppers should be taken in moderation so as not to swing the pendulum too far in one direction," Grey said.
How do you know if you've eaten too much spice? Grey said if you overdo it, you may suffer from dry cough, heartburn and acid reflux, as well as stomach pain and cramping. Gastritis, diarrhea and headaches are also symptoms.
Modern studies aren't the only source of wisdom about the health benefits of spice, said Grey. He pointed to "thousands of years of culinary evolution."
"In Mexico and Guatemala, it is the magic of the chili pepper that unlocks iron found in their corn-rich diets," the expert said.
"Throughout Asia and many cultures, it is the chili peppers and spices that are used for [their] anti-microbial properties, which help to kill parasites."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cal Fire awards $5.9M in forest health research grants to tackle wildfires
Cal Fire awards $5.9M in forest health research grants to tackle wildfires

Yahoo

time2 hours ago

  • Yahoo

Cal Fire awards $5.9M in forest health research grants to tackle wildfires

(FOX 5/KUSI) — In a push to strengthen California's forest resilience and wildfire preparedness, the California Department of Forestry and Fire Protection (Cal Fire) has awarded $5.9 million in grants to support 15 cutting-edge scientific research projects aimed at improving forest practices, land management, and public education. Announced on Friday, the funding comes from the Forest Health Research Program, a key component of the state's California Climate Investments initiative, supported by Greenhouse Gas Reduction Funds and the Wildfire and Forest Resilience budget package. 'These grant awards from the Forest Health Research Program are filling critical gaps in our knowledge of fire, forest, and other vegetation management,' said Chris Keithley, Cal Fire's assistant deputy director of Fire and Resource Assessment. 'The researchers we support fill knowledge gaps, evaluate effectiveness of management practices, develop new tools, and create vital information as we continue to work towards a more resilient California.' NASA research planes to conduct low-altitude flights over Southern California According to Cal Fire, the funded studies will explore understudied vegetation types such as chaparral, mountain meadows and oak woodlands, all of which play vital roles in California's ecological landscape. Other projects will advance tools for prescribed fire planning, forest monitoring and the cost-benefit evaluation of fuel treatment strategies, offering science-backed guidance to forest landowners, public agencies, fire response teams, and policymakers across the state. Among the recipients are academic and research institutions including the University of California, California State University, Colorado State University, Desert Research Institute, the USDA Forest Service, and Resources for the Future. Notably, six of the projects will be led by graduate students, fostering a new generation of experts in fire science and forest ecology. The grant-funded projects are expected to yield scientific publications, educational events, and decision-making tools that will support communities and agencies in mitigating wildfire risks and managing forest health more effectively, said Cal Fire officials. The Forest Health Research Program was created to address pressing questions related to climate change impacts, wildfire behavior, carbon storage, and land-use practices. Its goal, according to Cal Fire, is to provide the scientific foundation needed to develop long-term, sustainable forest management strategies across California. A full list of awarded projects and an interactive map of past and current research is available on the Forest Health Research website at: Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Goldman Sachs Reaffirms 'Buy' Rating on Iovance (IOVA) for Positive Amtagvi Data
Goldman Sachs Reaffirms 'Buy' Rating on Iovance (IOVA) for Positive Amtagvi Data

Yahoo

time3 hours ago

  • Yahoo

Goldman Sachs Reaffirms 'Buy' Rating on Iovance (IOVA) for Positive Amtagvi Data

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the 10 best healthcare penny stocks to buy according to analysts. Goldman Sachs reiterated its 'Buy' rating on Iovance's stock on June 3. The firm also maintained its $34.00 price target for Iovance shares. A close up of a lab technician in a protective suit, working with cells in a petri dish to develop innovative therapeutics for immune-related diseases. Goldman Sachs based its reaffirmation on new data that Iovance presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The ASCO data focused on Amtagvi, a tumor-infiltrating lymphocyte (TIL) therapy. The FDA approved the treatment in February 2024 for adult patients with unresectable or metastatic melanoma. The data supported the therapy's safety profile, which, according to Goldman Sachs, reinforces Amtagvi's potential as a significant treatment option. Goldman Sachs's analysts noted that the five-year follow-up data are unprecedented for any therapy in this heavily pretreated advanced melanoma population. To them, the data highlights the durability of Amtagvi's responses. The firm emphasized Amtagvi's successful US launch, with consistent patient demand, enhanced operations at Authorized Treatment Centers (ATCs), and improved out-of-spec rates (manufacturing quality metrics). It also highlighted the drug's first full calendar year of sales in 2025 as a key driver. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a commercial-stage biopharmaceutical company. It develops and markets cell therapies that harness a patient's own immune cells to treat solid tumors. Its lead product is Amtagvi, approved for advanced melanoma, and it also markets Proleukin. Iovance's pipeline includes candidates for cervical cancer, non-small cell lung cancer, and hematologic malignancies. While we acknowledge the potential of IOVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition

Yahoo

time3 hours ago

  • Yahoo

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 26, William Blair reaffirmed its 'Market Perform' rating for Maravai stock. The key factor influencing this move is the leadership changes at Maravai. A scientist performing a blood test on a patient using life sciences tools & services. Maravai has undergone a complete leadership overhaul since December last year. In December 2024, the company brought in Andy Eckert as the new independent Chairman of the Board. Later, Maravai installed Bernd Brust as CEO, replacing Trey Martin. Then, on June 25, a new press release indicated that Rajesh 'Raj' Asarpota would assume the position of Executive Vice President and Chief Financial Officer, effective June 30. According to William Blair, Brust and Asarpota are joining Maravai's top-level management when the company is undergoing 'a challenging operational transition period.' The analysts noted that the company 'faces approximately $66 million in headwinds in 2025 from declining COVID-related revenues.' As such, the analysts are optimistic that the fresh hands at Maravai's helm will inject more momentum into the transition. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a life sciences company. It provides specialized products that support the development of vaccines, drug therapies, diagnostics, and cell and gene therapies. Its operations span two segments: Nucleic Acid Production and Biologics Safety Testing. While we acknowledge the potential of MRVI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store